Laura L. Staples
FDA investigator
Appears on 1 document from 2015, mostly at sites in Tennessee. Most often cites design and construction features (21 CFR 211.42(c)(10)(iv)).
- 1
- Documents on file
- 9.0
- Observations per 483
- 2015
- First seen
- 2015
- Most recent
What they cite most
From 9 observations- 21 CFR 211.42(c)(10)(iv)Design and construction features3
- 21 CFR 211.111Time limitations on production1
- 21 CFR 211.113(b)Control of microbiological contamination1
- 21 CFR 211.166(a)Stability testing1
- 21 CFR 211.167(a)Special testing requirements1
- 21 CFR 211.28(a)Personnel responsibilities1
Activity by year
2015: 1
Where
Tennessee 1
Often inspects with
Is Laura L. Staples coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2015-08-20 | 483 Diabetes Corporation of AmericaAug 20, 2015 · Franklin, Tennessee | Franklin, Tennessee | 9 |
About this profile
What does Laura L. Staples inspect?
Laura L. Staples appears on 1 document on file covering 1 site, mostly in Tennessee.
What do they cite most often?
21 CFR 211.42(c)(10)(iv) (design and construction features), followed by 21 CFR 211.111 and 21 CFR 211.113(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Laura L. Staples is dated Aug 20, 2015.